Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Ligand Pharmaceuticals Inc (NASDAQ:LGND)

120.39
Delayed Data
As of 3:59pm ET
 +0.49 / +0.41%
Today’s Change
71.63
Today|||52-Week Range
131.84
+11.04%
Year-to-Date

Stock Price Forecast

The 7 analysts offering 12-month price forecasts for Ligand Pharmaceuticals Inc have a median target of 145.00, with a high estimate of 150.00 and a low estimate of 104.00. The median estimate represents a +20.44% increase from the last price of 120.39.

Analyst Recommendations

The current consensus among 7 polled investment analysts is to Buy stock in Ligand Pharmaceuticals Inc. This rating has held steady since April, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
$0.65
Sales
$25.6M
Reporting Date
May 04

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -0.91%
 
 
 
 
 
 
Growthannually 2.37%
 
 
 
 
 
 

Sales

Growthquarterly 20.78%
 
 
 
 
 
 
Growthannually 64.79%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.